Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
24/05/202115:02PR Newswire (US)Libtayo® (cemiplimab) Receives Positive CHMP Opinion for the Treatment in Europe of Two Advanced CancersNASDAQ:REGNRegeneron Pharmaceuticals Inc
22/05/202101:45PR Newswire (US)Teen Scientists and Engineers Win $5 Million at Largest Global High School STEM CompetitionNASDAQ:REGNRegeneron Pharmaceuticals Inc
20/05/202107:00PR Newswire (US)Libtayo® (cemiplimab-rwlc) Presentations at ASCO Highlight Expanding Clinical Data in Diverse CancersNASDAQ:REGNRegeneron Pharmaceuticals Inc
19/05/202106:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
18/05/202100:01PR Newswire (US)Phase 3 Data Presented at ATS 2021 Show REGEN-COV™ (casirivimab with imdevimab) Reduced Risk of Hospitalization or Death by...NASDAQ:REGNRegeneron Pharmaceuticals Inc
17/05/202123:59PR Newswire (US)Pivotal Data at ATS 2021 Show Dupixent® (dupilumab) Significantly Reduced Asthma Attacks and Improved Lung Function in Child...NASDAQ:REGNRegeneron Pharmaceuticals Inc
16/05/202122:29Dow Jones NewsCovid-19 Drugmakers Take On Your Favorite TV Shows to Tackle Vaccine HesitancyNASDAQ:REGNRegeneron Pharmaceuticals Inc
13/05/202103:30PR Newswire (US)Positive Phase 3 Libtayo® (cemiplimab) Results in Advanced Cervical Cancer Presented at ESMO Virtual PlenaryNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/05/202121:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/05/202121:14Dow Jones NewsRegeneron 1Q Revenue Increases, With Gain From Covid-19 Antibody CocktailNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/05/202120:30PR Newswire (US)Regeneron Reports First Quarter 2021 Financial and Operating ResultsNASDAQ:REGNRegeneron Pharmaceuticals Inc
03/05/202122:00PR Newswire (US)ATS 2021 Breaking News Session to Feature Pivotal Data on REGEN-COV™ (casirivimab with imdevimab) and Dupixent® (dupilumab...NASDAQ:REGNRegeneron Pharmaceuticals Inc
24/04/202106:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
24/04/202106:12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
24/04/202106:05PR Newswire (US)Regeneron Announces Investor Conference PresentationsNASDAQ:REGNRegeneron Pharmaceuticals Inc
23/04/202123:59PR Newswire (US)New Dupixent® (dupilumab) Analyses at Two Upcoming Dermatology Congresses Reinforce Long-term Safety and Efficacy Profile in...NASDAQ:REGNRegeneron Pharmaceuticals Inc
12/04/202121:16TipRanksRegeneron’s REGEN-COV Shown To Reduce COVID-19 Progression In Phase 3 TrialNASDAQ:REGNRegeneron Pharmaceuticals Inc
12/04/202118:48Dow Jones NewsCovid-19 Drug Prevents Symptomatic Disease in Study, Regeneron SaysNASDAQ:REGNRegeneron Pharmaceuticals Inc
12/04/202115:52Dow Jones NewsRoche's Phase 3 Trial of Casirivimab, Imdevimab Shows Cut Risk of Symptomatic Covid-19 InfectionsNASDAQ:REGNRegeneron Pharmaceuticals Inc
12/04/202115:15PR Newswire (US)Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COV™ (casirivimab with imdevimab) Significa...NASDAQ:REGNRegeneron Pharmaceuticals Inc
12/04/202115:00PR Newswire (US)Phase 3 Prevention Trial Showed 81% Reduced Risk of Symptomatic SARS-CoV-2 Infections with Subcutaneous Administration of REG...NASDAQ:REGNRegeneron Pharmaceuticals Inc
09/04/202123:20Dow Jones NewsRegeneron Pharma Covid-19 Treatment Recommended by National Institutes of HealthNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/04/202122:15PR Newswire (US)NIH COVID-19 Treatment Guidelines Strongly Recommend Use of REGEN-COV™ (casirivimab with imdevimab) in Outpatients at High ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/04/202106:05PR Newswire (US)Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021NASDAQ:REGNRegeneron Pharmaceuticals Inc
31/03/202110:04PR Newswire (US)NIH-sponsored Trial Finds EYLEA® (aflibercept) Injection Reduced Vision-threatening Complications by 68% after Two Years in ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
23/03/202117:29Dow Jones NewsRegeneron Covid-19 Antibody Drug Reduced Risk of Hospitalization, Death by 70% in Late-Stage TrialNASDAQ:REGNRegeneron Pharmaceuticals Inc
23/03/202117:00PR Newswire (US)Phase 3 Trial Shows REGEN-COV™ (casirivimab with imdevimab) Antibody Cocktail Reduced Hospitalization or Death by 70% in No...NASDAQ:REGNRegeneron Pharmaceuticals Inc
20/03/202101:43TipRanksKiniksa Wins FDA Nod For ARCALYST Injection therapy; Shares Pop After-HoursNASDAQ:REGNRegeneron Pharmaceuticals Inc
18/03/202111:57PR Newswire (US)Teen Scientists Win $1.8 Million at Virtual Regeneron Science Talent Search 2021 for Remarkable Research on Infinite Matching...NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/03/202121:41Dow Jones NewsRegeneron, Sanofi: Positive Libtayo Phase 3 Study in Advanced Cervical CancerNASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN